216 related articles for article (PubMed ID: 7536502)
1. Human heart mast cells: a definitive case of mast cell heterogeneity.
Patella V; de Crescenzo G; Ciccarelli A; Marinò I; Adt M; Marone G
Int Arch Allergy Immunol; 1995 Apr; 106(4):386-93. PubMed ID: 7536502
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
Marone G; Stellato C; Mastronardi P; Mazzarella B
Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200
[TBL] [Abstract][Full Text] [Related]
3. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
4. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
7. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
8. Human cardiac mast cells in anaphylaxis.
Genovese A; Rossi FW; Spadaro G; Galdiero MR; Marone G
Chem Immunol Allergy; 2010; 95():98-109. PubMed ID: 20519884
[TBL] [Abstract][Full Text] [Related]
9. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells.
Genovese A; Borgia G; Bouvet JP; Detoraki A; de Paulis A; Piazza M; Marone G
Int Arch Allergy Immunol; 2003 Dec; 132(4):336-45. PubMed ID: 14707465
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterization and functional importance of human heart mast cells.
Marone G; de Crescenzo G; Adt M; Patella V; Arbustini E; Genovese A
Immunopharmacology; 1995 Nov; 31(1):1-18. PubMed ID: 8655285
[TBL] [Abstract][Full Text] [Related]
11. Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization.
de Paulis A; Marinò I; Ciccarelli A; de Crescenzo G; Concardi M; Verga L; Arbustini E; Marone G
Arthritis Rheum; 1996 Jul; 39(7):1222-33. PubMed ID: 8670335
[TBL] [Abstract][Full Text] [Related]
12. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
13. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
14. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
15. Human heart as a shock organ in anaphylaxis.
Marone G; Genovese A; Varricchi G; Granata F
Allergo J Int; 2014; 23(2):60-66. PubMed ID: 26120516
[TBL] [Abstract][Full Text] [Related]
16. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
de Paulis A; Ciccarelli A; Marinò I; de Crescenzo G; Marinò D; Marone G
Arthritis Rheum; 1997 Mar; 40(3):469-78. PubMed ID: 9082935
[TBL] [Abstract][Full Text] [Related]
17. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
[TBL] [Abstract][Full Text] [Related]
18. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
Benyon RC; Robinson C; Church MK
Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
[TBL] [Abstract][Full Text] [Related]
19. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E.
Genovese A; Bouvet JP; Florio G; Lamparter-Schummert B; Björck L; Marone G
Infect Immun; 2000 Oct; 68(10):5517-24. PubMed ID: 10992448
[TBL] [Abstract][Full Text] [Related]
20. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
